Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2343346rdf:typepubmed:Citationlld:pubmed
pubmed-article:2343346lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:2343346lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:2343346lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:2343346pubmed:issue10lld:pubmed
pubmed-article:2343346pubmed:dateCreated1990-6-26lld:pubmed
pubmed-article:2343346pubmed:abstractTextTherapeutic requirements were determined for a group of 256 patients with rheumatoid arthritis (RA) attending the Rheumatic Diseases Unit in Cape Town. Two-thirds of the patients had received or were receiving physiotherapy and half occupational therapy. Antidepressants had been taken by 24.2%, and 31.3% had received tranquillisers. All the patients had received non-steroidal anti-inflammatory drugs and 84 (32.8%) oral corticosteroids. One hundred and eighty-two patients (71.1%) had received one or more intra-articular or intralesional corticosteroid injections. A remittive agent or immunomodulatory drug had been prescribed to 163 patients (63.7%). Half the patients had undergone one or more surgical procedures for their RA. The outcome of management was favourable in the majority of patients, 78.1% having little or no functional disability. The management of patients with RA requires a team effort involving many different health professionals, and patients often require multiple drugs for the control of their disease.lld:pubmed
pubmed-article:2343346pubmed:languageenglld:pubmed
pubmed-article:2343346pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2343346pubmed:citationSubsetIMlld:pubmed
pubmed-article:2343346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2343346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2343346pubmed:statusMEDLINElld:pubmed
pubmed-article:2343346pubmed:monthMaylld:pubmed
pubmed-article:2343346pubmed:issn0256-9574lld:pubmed
pubmed-article:2343346pubmed:authorpubmed-author:MeyersO LOLlld:pubmed
pubmed-article:2343346pubmed:authorpubmed-author:OrozMMlld:pubmed
pubmed-article:2343346pubmed:issnTypePrintlld:pubmed
pubmed-article:2343346pubmed:day19lld:pubmed
pubmed-article:2343346pubmed:volume77lld:pubmed
pubmed-article:2343346pubmed:ownerNLMlld:pubmed
pubmed-article:2343346pubmed:authorsCompleteYlld:pubmed
pubmed-article:2343346pubmed:pagination497-9lld:pubmed
pubmed-article:2343346pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:meshHeadingpubmed-meshheading:2343346-...lld:pubmed
pubmed-article:2343346pubmed:year1990lld:pubmed
pubmed-article:2343346pubmed:articleTitleTherapeutic requirements in rheumatoid arthritis.lld:pubmed
pubmed-article:2343346pubmed:affiliationDepartment of Medicine, Groote Schuur Hospital.lld:pubmed
pubmed-article:2343346pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2343346pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2343346lld:pubmed